The IHPK1 gene is disrupted at the 3p21.31 breakpoint of t(3;9) in a family with type 2 mellitus

Journal of Human Genetics

Volumn 49, Issue 7, 2004, Pages 360-365

  Kamimura, Junichi ^a,b,c   Wakui, Keiko ^d   Kadowaki, Hiroko ^e   Watanabe, Yukio ^a,b   Miyake, Kazuaki ^f   Harada, Naoki ^a,c,g   Sakamoto, Michiyo ^h   Kinoshita, Akira ^a,c   Yoshiura, Koh Ichiro ^a,c   Ohta, Tohru ^c,i   Kishino, Tatsuya ^c,i   Ishikawa, Mutsuo ^b   Kasuga, Masato ^f   Fukushima, Yoshimitsu ^c,d   Niikawa, Norio ^a,c   Matsumoto, Naomichi ^a,c,j  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^b ASAHIKAWA MEDICAL COLLEGE   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^d SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

^f KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g Kyushu Medical Science Nagasaki Laboratory   (Japan)

^h Yamagata City Hospital Saiseikan   (Japan)

ⁱ NAGASAKI UNIVERSITY   (Japan)

^j YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

3p21.31; 9q33.1; Chromosomal translocation; IHPK1; Positional cloning; Type 2 diabetes mellitus

Indexed keywords

ADOLESCENT; ARTICLE; CASE REPORT; CHROMOSOME 3P; CHROMOSOME BREAKAGE; FEMALE; GENE; GENE DISRUPTION; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; HUMAN; IHPK1 GENE; INSULIN RELEASE; MOLECULAR CLONING; MULTIGENE FAMILY; MUTATIONAL ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEOTIDE SEQUENCE; PHENOTYPE; RECIPROCAL CHROMOSOME TRANSLOCATION; ADULT; BLOOD SAMPLING; BROTHER; CHROMOSOME 3P21.31; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; DIET THERAPY; DISEASE PREDISPOSITION; FAMILY; FLUORESCENCE IN SITU HYBRIDIZATION; FLUORESCENCE MICROSCOPY; GLUCOSE BLOOD LEVEL; GLUCOSURIA; GRANDPARENT; HEMOGLOBIN BLOOD LEVEL; INOSITOL HEXAPHOSPHATE KINASE 1 GENE; JAPANESE (PEOPLE); KARYOTYPE; KINESIOTHERAPY; MALE; MIDDLE AGED; MOTHER; OBESITY; PRADER WILLI SYNDROME; SEQUENCE ANALYSIS;

GLUCOSE; HEMOGLOBIN A1C; INOSITOL HEXAPHOSPHATE KINASE 1 PROTEIN; INSULIN; ORAL ANTIDIABETIC AGENT; PHOSPHOTRANSFERASE; UNCLASSIFIED DRUG;

EID: 3843133857     PISSN: 14345161     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10038-004-0158-z     Document Type: Article

References (22)

1. Datson NA, Semina E, van Staalduinen AA, Dauwerse HG, Meershoek EJ, Heus JJ, Frants RR, den Dunnen JT, Murray JC, van Ommen GJ (1996) Closing in on the Rieger syndrome gene on 4q25: mapping translocation breakpoints within a 50-kb region. Am J Hum Genet 59:1297-1305
2. Deeb SS, Fajas L, Nemoto M, Pihlajamaki J, Mykkanen L, Kuusisto J, Laakso M, Fujimoto W, Auwerx J (1998) A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet 20:284-287
3. Flomen RH, Vatcheva R, Gorman PA, Baptista PR, Groet J, Barisic I, Ligutic I, Nizetic D (1998) Construction and analysis of a sequence-ready map in 4q25: Rieger syndrome can be caused by haploinsufficiency of RIEG, but also by chromosome breaks approximately 90 kb upstream of this gene. Genomics 47:409-413
4. Furuta H, Furuta M, Sanke T, Ekawa K. Hanabusa T, Nishi M, Sasaki H, Nanjo K (2002) Nonsense and missense mutations in the human hepatocyte nuclear factor-1 beta gene (TCF2) and their relation to type 2 diabetes in Japanese. J Clin Endocrinol Metab 87:3859-3863
5. Gloyn AL, Ellard S, Shepherd M, Howell RT, Parry EM, Jefferson A, Levy ER, Hattersley AT (2002) Maturity-onset diabetes of the young caused by a balanced translocation where the 20q12 break point results in disruption upstream of the coding region of hepatocyte nuclear factor-4alpha (HNF4A) gene. Diabetes 51:2329-2333
6. Hani EH, Suaud L, Boutin P, Chevre JC, Durand E, Philippi A, Demenais F, Vionnet N, Furuta H, Velho G, Bell GI, Laine B, Froguel P (1998) A missense mutation in hepatocyte nuclear factor-4 alpha, resulting in a reduced transactivation activity, in human late-onset non-insulin-dependent diabetes mellitus. J Clin Invest 101:521-526
7. Horikawa Y, Oda N, Cox NJ, Li X, Orho-Melander M, Hara M, Hinokio Y, Lindner TH, Mashima H, Schwarz PE, del Bosque-Plata L, Oda Y, Yoshiuchi I, Colilla S, Polonsky KS, Wei S, Concannon P, Iwasaki N, Schulze J, Baier LJ, Bogardus C, Groop L, Boerwinkle E, Hanis CL, Bell GI (2000) Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet 26:163-175
8. Iwasaki N, Cox NJ, Wang YQ, Schwarz PE, Bell GI, Honda M, Imura M, Ogata M, Saito M, Kamatani N, Iwamoto Y (2003) Mapping genes influencing type 2 diabetes risk and BMI in Japanese subjects. Diabetes 52:209-213
9. Kleinjan DJ, van Heyningen V (1998) Position effect in human genetic disease. Hum Mol Genet 7:1611-1618
10. Kusari J, Verma US, Buse JB, Henry RR, Olefsky JM (1991) Analysis of the gene sequences of the insulin receptor and the insulin-sensitive glucose transporter (GLUT-4) in patients with common-type non-insulin-dependent diabetes mellitus. J Clin Invest 88:1323-1330
11. Laakso M, Malkki M, Kekalainen P, Kuusisto J, Deeb SS (1994) Insulin receptor substrate-1 variants in non-insulin-dependent diabetes. J Clin Invest 94:1141-1146
12. Malecki MT, Jhala US, Antonellis A, Fields L, Doria A, Orban T, Saad M, Warram JH, Montminy M, Krolewski AS (1999) Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus. Nat Genet 23:323-328
13. Mori Y, Otabe S, Dina C, Yasuda K, Populaire C, Lecoeur C, Vatin V, Durand E, Hara K, Okada T, Tobe K, Boutin P, Kadowaki T, Froguel P (2002) Genome-wide search for type 2 diabetes in Japanese affected sib-pairs confirms susceptibility genes on 3q, 15q, and 20q and identifies two new candidate Loci on 7p and 11p. Diabetes 51:1247-1255
14. Nagase T, Seki N, Ishikawa K, Ohira M, Kawarabayasi Y, Ohara O, Tanaka A, Kotani H, Miyajima N, Nomura N (1996) Prediction of the coding sequences of unidentified human genes. VI. The coding sequences of 80 new genes (KIAA0201-KIAA0280) deduced by analysis of cDNA clones from cell line KG-1 and brain. DNA Res 3:321-329, 341-354
15. Novials A, Vidai J, Franco C, Ribera F, Sener A, Malaisse WJ, Gomis R (1997) Mutation in the calcium-binding domain of the mitochondrial glycerophosphate dehydrogenase gene in a family of diabetic subjects. Biochem Biophys Res Commun 231:570-572
16. Owen KR, Roland J, Smith K, Hattersley AT (2003) Adolescent onset Type 2 diabetes in a non-obese Caucasian patient with an unbalanced translocation. Diabet Med 20:483-485
17. Saiardi A, Erdjument-Bromage H, Snowman AM, Tempst P, Snyder SH (1999) Synthesis of diphosphoinositol pentakisphosphate by a newly identified family of higher inositol polyphosphate kinases. Curr Biol 9:1323-1326
18. Semina EV, Datson NA, Leysens NJ, Zabel BU, Carey JC, Bell GI, Bitoun P, Lindgren C, Stevenson T, Frants RR, van Ommen G, Murray JC (1996) Exclusion of epidermal growth factor and high-resolution physical mapping across the Rieger syndrome locus. Am J Hum Genet 59:1288-1296
19. Tanizawa Y, Riggs AC, Chiu KC, Janssen RC, Bell DS, Go RP, Roseman JM, Acton RT, Permutt MA (1994) Variability of the pancreatic islet beta cell/liver (GLUT 2) glucose transporter gene in NIDDM patients. Diabetologia 37:420-427
20. Triggs-Raine BL, Kirkpatrick RD, Kelly SL, Norquay LD, Cattini PA, Yamagata K, Hanley AJ, Zinman B, Harris SB, Barrett PH, Hegele RA (2002) HNF-1alpha G319S, a transactivation-deficient mutant, is associated with altered dynamics of diabetes onset in an Oji-Cree community. Proc Natl Acad Sci USA 99:4614-4619
21. Voglmaier SM, Bembenek ME, Kaplin AI, Dorman G, Olszewski JD, Prestwich GD, Snyder SH (1996) Purified inositol hexakisphosphate kinase is an ATP synthase: diphosphoinositol pentakisphosphate as a high-energy phosphate donor. Proc Natl Acad Sci USA 93:4305-4310
22. Waeber G, Delplanque J, Bonny C, Mooser V, Steinmann M, Widmann C, Maillard A, Miklossy J, Dina C, Hani EH, Vionnet N, Nicod P, Boutin P, Froguel P (2000) The gene MAPK8IP1, encoding islet-brain-1, is a candidate for type 2 diabetes. Nat Genet 24:291-295